| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10907643 | Experimental Hematology | 2005 | 12 Pages |
Abstract
Homozygosity for an on an F1 genetic background is essential for high-incidence/early-onset HS; myelopoiesis and HS coexist; and therapeutic transplantation may be feasible.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jane E. Barker, Susan A. Deveau, Sheila T. Compton, Karen Fancher, Janan T. Eppig,